Comparison of two procedures for sentinel lymph node detection in patients with endometrial cancer: A pilot study

Objective: The purpose of this study was to assess the feasibility and contribution of two intraoperative procedures of lymphatic mapping and sentinel node detection using a blue dye in surgically-staged patients with early stage endometrial cancer.

Methods and materials: In 25 cases of endometrial cancer, patent blue-V was injected into the subserosal myometrium (13 cases, SM group) or cervico-subserosal myometrium (12 cases, CSM group) during a surgical staging procedure. Laparoscopically-assisted vaginal hysterectomy and pelvic lymphadenectomy were completed successfully in 23 women out of 24 laparoscopically-staged patients (95.8%). One patient with FIGO stage IIa was indicated for a radical abdominal surgery.

Results: A deposition of the blue dye was found in at least one pelvic lymph node (LN) in eight out of 13 cases (61.5%) in the SM group compared with ten out of 12 cases (83.3%) in the CSM group (p = 0.378). The mean number of dye-colored LN (DCLN) was 1.15 (SM group) and 2.5 (CSM group), respectively (p = 0.05). The rate of DCLN/LN was 15/188 (SM group) versus 30/190. respectively (p = 0.03). An uptake of the blue bye was observed in a total of 45 out of 388 LN.

Conclusion: An intraoperative combination of cervico-subserosal myometrium application of the blue dye allows successful detection (83.3%) of sentinel LN in patients with endometrial cancer. Comparing SM and CSM groups the statistical significant difference was found in the DCLN/LN rate and mean number of sentinel lymph nodes (p = 0.03, p = 0.05, respectively). Clinical validity of this surgical procedure must be assessed prospectively.

Sentinel lymph node detection; Endometrial cancer

[1] National Cancer Registry: "Annual Report 1989". ICMR, 1991, 20.

[2] Burke T. W., Levenback Ch., Tornos C., Morris M., Wharton J. T., Gershenson D. M.: "Intra-abdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in women with high risk endometrial cancer: results of a pilot study". Gynecol. Oncol., 1996, 62, 169.

[3] Morton D. L., Wen D.R., Wong J. H., Economou J. S., Cagle L. A., Storm F. K. et al.: "Technical details of intraoperative lymphatic mapping for early stage melanoma". Arch. Surg., 1992, 127, 392.

[4] Holub Z., Kliment L., Lukac J., Voracek J.: "Laparoscopically assisted intraoperative lymphatic mapping in endometrial cancer: preliminary results". Eur. J. Gynaec. Oncol., 2001, 22, 118.

[5] Childers J. M., Brzechffa P. R., Hatch K. D.: "Laparoscopically assisted surgical staging (LASS) of endometrial cancer". Gynecol. Oncol., 1953, 51, 33.

[6] Bilchik A. J., Giuliano A., Essner R., Bostick P., Kelemen P., Foshag J. et al.: "Universal application of intraoperative lymphatic mapping and sentinel lymphadenectomy in solid neoplasms". Cancer J. Sci. Am., 1998, 4, 351.

[7] P arry-Jones E.: "Lymphatics of the vulva". J. Obstet. Gynecol. Br. Cwlth., 1963, 70, 751.

[8] Morrow M.,R ademaker A. W., Bethke K. P., Talamonti M. S., Dawes L. G., Clauson J. et al.: "Learning sentinel node biopsy: results of a prospective randomized trial of two techniques". Surgery, 1999, 126, 714.

[9] Morton D. L., Thompson J. F., Essner R., Elashoff R., Stern S. L., Nieweg O. E. et al.: "Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma". Ann. Surg., 1999, 230, 453.

[10] Veronesi U., P aganelli G., Galimberi V., Viale G.: "Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes". Lancet, 1997, 349, 1864.

[11] Kelemen P. R., VanHerle A. J., Giuliano A. E.: "Sentinel lymphadenectomy in thyroid malignant neoplasms". Arch. Surg., 1998, 133, 288.

[12] Levenback Ch.,B urke T. W.,M orris M.,M alpica A.,L ucas K. R., Gershenson D. M.: "P otential applications of intraoperative lymphatic mapping in vulvar cancer". Gynecol. Oncol., 1995, 59, 216.

[13] Medl M., Peters E., Schutz P., Vesely M., Sevelda P.: "First report of lymphatic mapping with isosulfan blue dye and sentinel node biopsy in cervical cancer". Anticancer Res., 2000, 20, 1134.

[14] O'Boyle J. D.,C oleman R. L.,B ernstein S. G.,L ifshitz S., Muller C. Y., Miller D.: "Intraoperative lymphatic mapping in cervix patients udergoing radical hysterectomy". Gynecol. Oncol., 2000, 79, 243.

[15] Dargent D., Martin X., Mathevet P.: "Laparoscopic assessment of the sentinel lymph node in early stage cervical cancer". Gynecol Oncol., 2000, 79, 411.

[16] Dargent D., Martin X., Roy M. et al.: "Identification of sentinel node with laparoscopy in cervical cancer". 31. Meet. Soc. Gynecol. Oncol. Abst., 2000, 41, 241.

[17] Malur S., Krause A., Kohler Ch., Schneider A.: "Sentinel lymph node detection in patients with cervical cancer". Gynecol. Oncol., 2001, 80, 254.

[18) Joosten J. J., Strobbe L. J., Wauters C. A., Pruszynski M.,Wobbes T., Ruers T. J.: "lntraoperative lymphatic mapping and the sentinel node concept of colorectal carcinoma". Br. J. Surg., 1999, 86, 482.

[19] Esser S., Reilly W. T., Riley L.B., Eyvazzadeh C., Arcona S.: "The role of sentinel lymph node mapping in staging of colon and rectal cancer". Dis. Colon Rectum, 2001, 44, 850.

[20] Wood T. F., Saha S.,M orton D. L., Tsoulias G. J., Rangel D., Hutchinson W.: ·'Validation of lymphatic mapping in colorectal cancer: in vivo, ex vivo and laparoscopic techniques". Ann. Surg. Oncol., 2001, 8, 150.

[21] Cote R. J., Peterson H.F., Chaiwun B. et al.: "Role of immunohis tochemical detection of lymph node metastases in metastases in management of breast cancer". Lancet, 1999, 354, 896.

[22] Bembenek A., Haensch W., Schneider U.. Markwardt J., Schlag P M.: "Immunohistochemical detection of lymph-node metastases". Lancet, 2000, 355, 144.

[23] Ramirez P. T., Levenback Ch.: "Sentinel nodes in gynecologic malignancies". Curr. Opin. Oneal., 2001, 13, 403.